Edit |   |
---|---|
Antigenic Specificity | SOST, Human (Blosozumab biosimilar) |
Clone | Blosozumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FuncS, IF, Neut, ELISA, FCM, IP |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human SOST Recombinant Antibody (Blosozumab). Blosozumab binds SOST, a negative regulator of osteoblast activity. Blocking SOST activity can lead to increased bone density. Blosozaumab has been studied with regards to the treatment of osteoporosis in both men and postmenopausal women. Clinical trials with Blosozumab have shown the antibody to be well tolerated and effective in producing a bone anabolic effect. |
Immunogen | n/a |
Other Names | Anti-SOST Recombinant Antibody, Research Grade Blosozumab, Anti-Human SOST Recombinant Antibody(Blosozumab), LY2541546, Antibody Drug Analogues, Monoclonal Antibody, YR1254, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1132758-87-2 |
Catalog # | YR1254 |
Price | please inquire |
Order / More Info | SOST, Human (Blosozumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |